ARL14 and non-small cell lung carcinoma: Notably, previous studies confirmed that increased ARL14 expression was strongly associated with poor survival of NSCLC patients, while the decreased ZDHHC11B and HLF expression predicted poor survival of NSCLC patients [5, 47, 55].